BAP1 and neoplasm: In summary, the data presented here nominate BAP1 methylation as a streamlined, highly informative, cost-effective, and readily actionable test that can be performed on bulk tumor samples and that should be prospectively evaluated for its value as a stand-alone prognostic test to identify high-risk UM patients.